Peter J. Godolphin

Also affiliated with University College London, University of Rostock

Decision SciencesMathematicsMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis”.

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis

PLOS ONE(2022)10.1371/journal.pone.0270668

N/A

0.500DataRank · unranked

27 citations

David J. Fisher, Lindsay R. Berry, Lennie P. G. Derde, Janet V. Diaz, Anthony C. Gordon +8 more

Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5070

N/A

0.330DataRank · unranked

8 citations

Akash Roy, Siyuan S Guo, Larysa Rydzewska, Peter J. Godolphin, Maha Hussain +15 more

Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.01535

N/A

0DataRank · unranked

29 citations

Akash Roy, Larysa Rydzewska, Siyuan Guo, Peter J. Godolphin, Maha Hussain +15 more

Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00219-5

N/A

0DataRank · unranked

11 citations

Peter J. Godolphin, David J. Fisher, Peter Horby, Mikhail Kosiborod, Judith S. Hochman +18 more

1615P A new prognostic model of overall survival (OS) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1696

N/A

0DataRank · unranked

0 citations

Bingcheng Luo, Shuo Guo, Larysa Rydzewska, Peter J. Godolphin, M.K. Parmar +6 more

Examining covariate-specific treatment effects in individual participant data meta-analysis: Framing aggregation bias in terms of trial-level confounding and funnel plots

Research Synthesis Methods(2025)10.1017/rsm.2025.10043

N/A

0DataRank · unranked

0 citations

Joseph S. Koopmeiners, Jamie Hartmann‐Boyce, Peter J. Godolphin, Abdel G. Babiker, Giota Touloumi +3 more